Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012
2018/04/16 by Melina Arnold, Esther de Vries, David C. Whiteman +4 · 32 citations
Medicine · #Cutaneous Melanoma Detection and Management #Skin Protection and Aging #Allergic Rhinitis and Sensitization
paper · doi:10.1002/ijc.31527
Abstract
Ultraviolet radiation (UVR) is a strong and ubiquitous risk factor for cutaneous melanoma, emitted naturally by the sun but also artificial sources. To shed light on the potential impact of interventions seeking to reduce exposure to UVR in both high and low risk populations, we quantified the number of cutaneous melanomas attributable to UVR worldwide. Population attributable fractions and numbers of new melanoma cases in adults due to ambient UVR were calculated by age and sex for 153 countries by comparing the current melanoma burden with historical data, i.e., the melanoma burden observed in a population with minimal exposure to UVR. Secondary analyses were performed using contemporary melanoma incidence rates in dark-skinned African populations with low UVR susceptibility as reference. Globally, an estimated 168,000 new melanoma cases were attributable to excess UVR in 2012, corresponding to 75.7% of all new melanoma cases and 1.2% of all new cancer cases. This burden was concentrated in very highly developed countries with 149,000 attributable cases and was most pronounced in Oceania, where 96% of all melanomas (representing 9.3% of the total cancer burden) were attributable to excess UVR. There would be approximately 151,000 fewer melanoma cases worldwide were incidence rates in every population equivalent to those observed in selected low-risk (dark-skinned, heavily pigmented) reference populations. These findings underline the need for public health action, an increasing awareness of melanoma and its risk factors, and the need to promote changes in behavior that decrease sun exposure at all ages.
Citations
Cited by
- Global burden of cutaneous melanoma incidence attributable to ultraviolet radiation in 2022
- Long-term variability of human health-related solar ultraviolet-B radiation doses from the 1980s to the end of the 21st century
- primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma
- Effect of daily sunscreen application on vitamin D: findings from the open-label randomized controlled Sun-D Trial
- Clinical and experimental treatment of advanced melanoma with a focus on immunotherapy
- The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway
- Acral Melanoma Incidence and Survival Trends in 1990–2020: A Nationwide, Population-based Study
- Population attributable fractions continue to unmask the power of prevention. [europepmc]
- Antiproliferative Activity of Non-Calcemic Vitamin D Analogs on Human Melanoma Lines in Relation to VDR and PDIA3 Receptors. [europepmc]
- Sun Exposure and Melanoma, Certainties and Weaknesses of the Present Knowledge. [europepmc]
- Vitamin D and its low calcemic analogs modulate the anticancer properties of cisplatin and dacarbazine in the human melanoma A375 cell line. [europepmc]
- Implementation of the SunSmart program and population sun protection behaviour in Melbourne, Australia: Results from cross-sectional summer surveys from 1987 to 2017. [europepmc]
- Are Environmental Interventions Targeting Skin Cancer Prevention among Children and Adolescents Effective? A Systematic Review. [europepmc]
- Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study. [europepmc]
- The discovery and development of binimetinib for the treatment of melanoma. [europepmc]
- Environmental effects of stratospheric ozone depletion, UV radiation and interactions with climate change: UNEP Environmental Effects Assessment Panel, update 2019. [europepmc]
- Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study. [europepmc]
- Vitamin D and cardiovascular health. [europepmc]
- Daily Lifestyle and Cutaneous Malignancies. [europepmc]
- Circadian clock protein BMAL1 regulates melanogenesis through MITF in melanoma cells. [europepmc]
- Trend Shifts in Age-Specific Incidence for In Situ and Invasive Cutaneous Melanoma in Sweden. [europepmc]
- The Role of the BH4 Cofactor in Nitric Oxide Synthase Activity and Cancer Progression: Two Sides of the Same Coin. [europepmc]
- Indoor Tanning and the Risk of Overall and Early-Onset Melanoma and Non-Melanoma Skin Cancer: Systematic Review and Meta-Analysis. [europepmc]
- Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts. [europepmc]
- Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. [europepmc]
- The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. [europepmc]
- Association of UV Radiation Exposure, Diagnostic Scrutiny, and Melanoma Incidence in US Counties. [europepmc]
- The effects of exposure to solar radiation on human health. [europepmc]
- Global trends in cutaneous malignant melanoma incidence and mortality. [europepmc]
- Plaque Psoriasis Exacerbation and COVID-19 Vaccination: Assessing the Characteristics of the Flare and the Exposome Parameters. [europepmc]
- Ultraviolet (UV) radiation: a double-edged sword in cancer development and therapy. [europepmc]
- A multimodal vision foundation model for clinical dermatology. [europepmc]
Related